Stocks · Health care · Pharmaceutical Preparations

Organon & Co.

OGN Clue Score37
United States Fiscal year ends December CIK 0001821825 Results filed 30 Apr 2026

What the insiders did Net buying

By person

23 insiders · 14 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Carrie Smith Cox
Executive Chair
$602.35K (2)
—
+$602.35K
90,338
0.0344%
$1.23M
+624.5%
Lynette Holzbaur
SVP and Corporate Controller
$353.08K (1)
—
+$353.08K
52,851
0.0201%
$717.19K
+386.7%
Kevin Ali
Chief Executive Officer
$299.37K (1)
—
+$299.37K
282,731
0.1077%
$3.84M
+1,799%
Juliana Papa Drinane
Head of Mfg & Supply
—
$200.31K (1)
−$200.31K
18,475
0.0070%
$250.70K
+50.1%
Kirke Weaver
Gen. Counsel & Corp. Secy.
$123.99K (2)
—
+$123.99K
92,639
0.0353%
$1.26M
+2,144%
Ma. Fatima Francisco
Director
$101.37K (1)
—
+$101.37K
3,000
0.0011%
$40.71K
—
Matthew M Walsh
Chief Financial Officer
$100.55K (1)
—
+$100.55K
212,746
0.0810%
$2.89M
+32,530%
Aaron Falcione
Chief Human Resources Officer
$48.24K (1)
—
+$48.24K
101,431
0.0386%
$1.38M
+2,072%
Daniel Karp
Executive VP, Corp. Dev.
$28.83K (1)
—
+$28.83K
69,548
0.0265%
$943.77K
+245.9%
Joseph T. Morrissey Jr.
Interim CEO
—
—
—
123,123
0.0469%
$1.67M
+1,852%
Rachel A Stahler
Chief Information Officer
—
—
—
116,105
0.0442%
$1.58M
+1,465%
Vittorio Nisita
Head of Global Business Svcs
—
—
—
70,619
0.0269%
$958.30K
+1,731%
Susanne Fiedler
Chief Commercial Officer
—
—
—
53,113
0.0202%
$720.74K
+1,719%
Kathryn DiMarco
Corporate Controller
—
—
—
38,740
0.0148%
$525.70K
+4,724%
Ferreira Juan Camilo Arjona
Head of R&D & CMO
—
—
—
37,432
0.0143%
$507.96K
—
Sandra Milligan
Head of Research & Development
—
—
—
28,599
0.0109%
$388.09K
+1,230%
Geralyn S Ritter
Head of Ext. Affairs and ESG
—
—
—
10,755
0.0041%
$145.95K
+4,168%
Deborah H Telman
EVP GC & Corporate Secretary
—
—
—
7,688
0.0029%
$104.33K
—
Rochelle B Lazarus
Director
—
—
—
635
0.0002%
$8.62K
0.0%
Deborah R Leone
Director
—
—
—
10
<0.0001%
$135.70
0.0%
Grace Puma Whiteford
Director
—
—
—
5
<0.0001%
$67.85
0.0%
Shalini Sharp
Director
—
—
—
2
<0.0001%
$27.14
0.0%
Merck & Co., Inc. entity
10% owner
—
—
—
0
0.0000%
$0.00
−100.0%